On Monday, July 29, 2013, leading lung disease researchers from around the globe will participate in the fifth biennial “Stem Cells and Cell Therapies in Lung Biology Conference” at the University of Vermont (UVM). Since the meeting’s initiation eight years ago by UVM Professor of Medicine and lung specialist Daniel Weiss, M.D., Ph.D., the field has achieved a number of milestones, including promising strides in the area of bioengineering new lungs. More than 150 participants are expected to attend the invitation-only conference, which takes place at the Sheraton Burlington Hotel and Conference Center on July 29 and at the Dudley H. Davis Center at UVM July 30 through August 1, 2013.
Lung diseases, and especially chronic obstructive pulmonary disease (COPD), which includes conditions such as emphysema and chronic bronchitis, are increasing in prevalence, with COPD predicted to be the third leading cause of death worldwide by the year 2020. With a reported $49.9 billion in related health care costs in 2009, the need to both prevent disease and identify new treatments is critical.
Read the entire article at:
For more information about Idiopathic Pulmonary Fibrosis please visit our website www.ipftoday.com and don’t forget to like us on www.facebook.com/IPFToday
